Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
32
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
27
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
So-Young International
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Transition To Franchise Model And Clinic Expansion Will Strengthen Future Prospects
Key Takeaways Rapid clinic expansion and franchise model promise increased revenue and improved net margins through reduced costs and operational efficiency. Vertical integration and data insights bolster competitive advantage, enhancing profitability and boosting overall earnings.
View narrative
US$5.70
FV
29.0% undervalued
intrinsic discount
37.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
25 days ago
author updated this narrative
Tapestry
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Global Markets And Digital Capabilities Will Shape Future Upside
Key Takeaways Expanding younger customer base and international markets is driving long-term revenue growth and greater diversification. Investments in digital, product innovation, and operational efficiencies are supporting higher margins and sustained earnings growth.
View narrative
US$114.56
FV
13.0% undervalued
intrinsic discount
3.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
4 days ago
author updated this narrative
SPG
SP Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
Key Takeaways Strong growth in proprietary products and a new factory in Atlanta suggest potential for increased revenue and improved margins. Commitment to sustainability and a share buyback program may boost eco-conscious customer appeal and shareholder value.
View narrative
DKK 370.00
FV
26.8% undervalued
intrinsic discount
4.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Chroma ATE
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Accelerating AI And 5G Trends Will Drive Industry Expansion
Key Takeaways Accelerating demand from AI, high-performance computing, and electrification trends is fueling strong order growth and expanding market opportunities. Emphasis on advanced, proprietary testing platforms and disciplined margin management supports pricing power, technology leadership, and sustained profitability improvements.
View narrative
NT$513.33
FV
3.2% undervalued
intrinsic discount
14.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Fasadgruppen Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Cost Savings Of SEK 20 Million Will Improve Operational Efficiency
Key Takeaways Successful integration and strategic acquisitions enhance future revenue growth prospects, improve margins, and position Fasadgruppen well in professional markets. Focus on deleveraging and operational efficiency should strengthen the financial structure and improve profitability metrics.
View narrative
SEK 32.00
FV
9.4% overvalued
intrinsic discount
9.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
10 days ago
author updated this narrative
Hongkong Land Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Marquee Asset Repositioning And Asian Expansion Will Create Lasting Value
Key Takeaways Prudent capital management, asset repositioning, and a growing fund management platform are expected to support earnings growth and improve shareholder value. Strategic expansion in high-growth cities and operational streamlining aim to boost recurring revenues, reduce volatility, and enhance profitability.
View narrative
US$6.36
FV
3.2% undervalued
intrinsic discount
5.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
10 days ago
author updated this narrative
Embecta
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
GLP-1 Partnerships Will Expand Global Healthcare Reach
Key Takeaways Strategic collaborations and product innovation position Embecta to capitalize on growing GLP-1 adoption and rising global diabetes prevalence, supporting durable revenue growth. Operational efficiencies, expanding into emerging markets, and improved financial flexibility enable Embecta to pursue growth while enhancing margins and shareholder value.
View narrative
US$16.67
FV
13.7% undervalued
intrinsic discount
-0.34%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
4 days ago
author updated this narrative
Sonic Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Recent Acquisitions And Cost Control Will Boost Future Efficiency In Pathology Testing
Key Takeaways Margin expansion driven by labor cost optimization and enhanced cost control positively impacts net margins and earnings. M&A activity in Europe and strategic acquisitions boost revenue, EBITDA, and operational efficiencies, improving overall earnings.
View narrative
AU$28.25
FV
12.9% undervalued
intrinsic discount
7.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
3
users have commented on this narrative
51
users have followed this narrative
Updated
narrative
Borosil
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Shifting To Domestic Production Will Expand Capacity And Reduce Import Reliance
Key Takeaways Expansion of production capacity and focus on premium lines is set to enhance revenue growth and strengthen brand leadership. Shift to online sales and domestic production could improve revenue and margins, despite short-term cost pressures.
View narrative
₹382.50
FV
10.1% undervalued
intrinsic discount
12.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies